{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135895","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.740138+00:00","generated_at":"2026-05-29T04:13:19.342144+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Revelation Biosciences regains compliance with Nasdaq stockholders' equity requirement","bullets":["Reported stockholders' equity of $2.67M as of Sep 30, 2024, meeting the $2.5M minimum.","Entered warrant inducement letters on Dec 3, 2024; 4,064,040 warrants exercised at $1.00/share.","Gross proceeds from warrant exercises approximately $4.1M; equity now ~$6.0M, cash ~$7.1M.","Company believes it is compliant with Nasdaq Listing Rule 5550(b)(1) as of Dec 12, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135895","json":"https://secwatch.observer/filing/0000950170-24-135895.json","markdown":"https://secwatch.observer/filing/0000950170-24-135895.md","text":"https://secwatch.observer/filing/0000950170-24-135895.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/0000950170-24-135895-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/revb-20241212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:13:19.342144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}